Akili’s Operating Plan for 2023 Focuses on EndeavorRx Commercialization and Growth
Akili, a leading digital medicine company, has reported a 37% increase in …
Akili, a leading digital medicine company, has reported a 37% increase in …
Dr. Kollins brings decades of experience driving novel approaches to psychopharmacology and ADHD treatment BOSTON--(BUSINESS WIRE)--$AKLI #ADHD--Akili, Inc., a leading commercial digital medicine company, today announced the appointment of Scott Kolli...
Akili, Inc. common stock to begin trading on Nasdaq under the ticker symbo…
Pivotal study follows successful Phase 2 trial, which demonstrated improvements in attention function as compared to both treatment as usual and single task video game groups Pivotal Data Readout expected in 2H2023 BOSTON--(BUSINESS WIRE)--PureTech H...
Pivotal study follows successful Phase 2 trial, which demonstrated improvements in attention function as compared to both treatment as usual and single task video game groups Pivotal Data Readout expected in 2H2023 BOSTON--(BUSINESS WIRE)--Akili Inte...
The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined patient experience BOSTON--(BUSINESS WIRE)--PureTech Hea...
The Roblox vision for bringing people together through shared experiences, plus the Akili commitment to a new era of cognitive medicine, make the companies ideal partners to deliver a reimagined patient experience BOSTON & SANTA MONICA, Calif.--(BUSIN...
Akili Interactive, a leading prescription digital therapeutics company and…
Akili has published data backing the efficacy of its childhood attention-de…
At CES 2019, the digital therapeutic company's CEO and cofounder described …